DSM-Firmenich: How To Evaluate A Chemical Giant

DSM-Firmenich is a high-quality specialty chemicals company focused on inelastic, high-margin nutrition, health, and beauty ingredients. Following the divestment of its volatile animal nutrition segment, DSM-Firmenich now boasts a robust A-rated balance sheet, strong FCF, and a well-covered 3%+ dividend. Despite historical premium valuations, I assign a forward P/E of 17-18x, reflecting justified but moderate premiumization versus peers, with a price target of €67.8/share.
Open original source